CPINV's lease holds will expire from 2026 till 2043. The first negative impact of two leases that expire in FY26 was visible in the 4Q24/1Q25 rental income. We believe there is a lot of confusion in the investor community around these leases and we aim to debunk some myths with this note. No matter how these scenario's unfold, there will be negative rent reversion on these leases ranging from –60 to -20%. Given the negative rental income drag and the limited upside to our unchanged TP of EUR 14...
A director at Gimv NV bought 2,250 shares at 44.642EUR and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...
1M Performance - Absolute: During May'25 (1M period), the KBCS Holdings Universe posted a return of +2.2% which was mainly driven by multi-asset holdings (+2.6%) while single-asset holdings posted a smaller return of +1.2%. The 3 top performers during the period were Gimv (+12.1%), KBC Ancora (+11.1%) and Ackermans & van Haaren (+4.1%) while the 3 worst performers were Solvac (-2.8%), Groupe Bruxelles Lambert (-0.8%) and Heineken Holding (-0.3%). YTD Performance - Relative: On a YTD basis (as o...
Ackermans & van Haaren: Solid 1Q25. Ascencio: Resilient results. Gimv: NAV a tad higher than expected, underlying companies surprisingly strong. IBA: Soft start in Technologies, 2025 and 2028 guidance reiterated. OCI: In-line 1Q25 trading update. Vopak: IPO of AVTL - value coming to the surface
Gimv reported another record year. Net profit reached €219m or €7.5ps. Portfolio result was €300m, up 19.3% YoY. Investments surged to €336.1m, including €267m in eight new companies and two roll-over's. Divestments totalled €560m from exits in Mega, United Dutch Breweries, Köberl, rehaneo, and Medi-markt. The book value of these stakes was €200m, implying a money multiple of 2.4x and IRR of 14.0%. NAVps stood at €53.3, slightly down from €53.4 YoY due to the capital increase, but up 14.6% on a ...
CFE's 1Q25 trading update underscored our view that end market conditions remain challenging in the short-to-medium term. Revenue declined by c.10% YoY in 1Q25 and the company reiterated its FY25 guidance, expecting a moderate decline in top line but a net profit close to the level reached last year. This was a positive and highlights that project-specific issues no longer significantly impact the underlying profitability of CFE. Our new, now in line with company guidance, FY25F net profit estim...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.